Xarelto Lawsuits Allege Undisclosed Risk of Internal Bleeding
April 27, 2017
More than 18,000 patients have filed lawsuits alleging that the blood-thinning medication Xarelto caused them to suffer internal bleeding, the risk of which they allege was not disclosed to them. Johnson & Johnson and Bayer jointly developed Xarelto, which was approved by the FDA in 2011 to be u[...]
Continue Reading
$70M Talcum Powder Cancer Verdict Against Johnson & Johnson
November 11, 2016
On October 27, 2016, a Missouri jury took only three hours to return its verdict in favor of a 62-year-old California woman against Johnson & Johnson for her terminal ovarian cancer that she alleged was due to her use of Johnson & Johnson’s talcum powder over the period of more than fo[...]
Continue Reading
Maryland Warns Against Use Of Nurse Assist Saline Flush Syringes
October 9, 2016
The Maryland Department of Health and Mental Hygiene (DHMH) announced on October 4, 2016 that it was issuing a recommendation that any healthcare facilities, providers or anyone else who has received Nurse Assist prepackaged, three-, five- and 10-milliliter syringes of saline flush immediately disc[...]
Continue Reading
$70M Risperdal Verdict
July 25, 2016
On July 1, 2016, a Philadelphia jury returned its verdict in the amount of $70 million against Janssen Pharmaceuticals, Inc., which manufactures the antipsychotic medication Risperdal. The Philadelphia verdict is the largest verdict so far in the mass tort litigation involving Risperdal claims that [...]
Continue Reading
Pennsylvania Superior Court Affirms $3M Topamax Award
May 12, 2016
In its non-precedential decision filed on May 11, 2016, the Superior Court of Pennsylvania (“Superior Court”) affirmed a $3 million Pennsylvania jury verdict in favor of the parents of a child born with a cleft lip and palate that the plaintiffs alleged were due to defendant Janssen[...]
Continue Reading
$72M Talc Verdict Against Johnson & Johnson
March 9, 2016
On February 22, 2016, a Missouri jury awarded $72 million to the estate of a woman who claimed that the ovarian cancer that caused her death in 2015 was as a result of the Johnson & Johnson talcum powder-based products that she used on a daily basis for many years. The St. Louis, Missouri[...]
Continue Reading
Kentucky Settles Two Pharmaceutical Cases For $39.5M
January 7, 2016
The Attorney General of Kentucky announced on December 23, 2015 that Kentucky had settled two pharmaceutical cases on December 22, 2015 that it had brought against Purdue Pharma regarding its opiod prescription medication, OxyContin, and against Janssen Pharmaceuticals, a subsidiary of Johnson &am[...]
Continue Reading
Zofran Lawsuit Alleges Serious Birth Defects
November 12, 2015
On September 29, 2015, a federal lawsuit was filed in California by the parents of a child born with a serious heart defect that they contend was caused by the mother’s off-label use of Zofran that was prescribed by her doctor for nausea during her pregnancy. The defendant is GlaxoSmithKline [...]
Continue Reading
First Tylenol Liver Damage Trial Ends In Defense Verdict
October 29, 2015
On October 16, 2015, a jury in New Jersey absolved Johnson and Johnson’s McNeil Consumer Healthcare subsidiary from liability to the plaintiff for her liver damage allegedly caused by taking Tylenol (acetaminophen), after a three-week trial. The 55-year-old plaintiff had alleged that the manu[...]
Continue Reading
